August 24, 2020
The Patent Trial and Appeal Board has refused to invalidate three different patents covering Adapt Pharma Ltd.'s opioid overdose treatment Narcan, two of which had a different fate in district court.
August 28, 2019
The Patent Trial and Appeal Board has agreed to review a patent covering the opioid overdose treatment Narcan, but turned away two other challenges to the same patent as part of a larger effort to nip redundant reviews.